Fredun Pharmaceuticals achieves milestone in Pet Care Division

The company achieved 100% capacity utilisation in the division. These accomplishments stand as a testament to the company's dedication and vision

Jemperli plus chemotherapy approved in the US as the first new frontline treatment option for dMMR/MSI-H primary advanced or recurrent endometrial cancer

Jemperli is the only immuno-oncology treatment approved in the frontline setting for this patient population in combination with chemotherapy

Biocon Foundation releases 2nd edition of consensus guidelines for head & neck cancer

Marks the World Head & Neck Cancer Day at the OCTF Conference

Teva Pharmaceuticals engages Honeywell to help reduce carbon impact

Teva will leverage Honeywell’s ‘Energy as a Service’ (EaaS) model

Update on medical colleges in aspirational districts: PIB

AIIMS established in Bilaspur, Nagpur, Rae Bareli and Gorakhpur

India brings traditional medicine at the forefront of India’s G20 presidency discourse: Amitabh Kant

Traditional medicine effectively highlighted in all health and engagement working groups meeting and Ministry of Ayush acknowledges these efforts

Lonza delivers 5.6% CER sales growth and 30% CORE EBITDA margin

Good momentum in commercial CDMO business

Tillotts Pharma and TVM Capital form Mage Biologics to develop oral antibody therapy for ulcerative colitis

Mage Biologics to develop a monoclonal antibody targeting ulcerative colitis

PNB Housing and PVRI launch Pehel Eye Mitra to deliver free transport services to eye patients

Evonik and Heraeus cooperate to expand the range of services for highly potent API

Evonik specializes in mid- to large-scale, later clinical phase HPAPIs